Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Circulation

• Publication date

  1997-01-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.95.1.240PMID 8994442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.

  1996cited by this paper
• Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.

  1996cited by this paper
• Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.

  1996cited by this paper
• Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.

  1996cited by this paper
• Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.

  1995cited by this paper
• In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats.

  1995cited by this paper
• Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats

  1995cited by this paper
• Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension.

  1995cited by this paper
• No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats

  1995cited by this paper
• Endothelin: potential role in hypertension and vascular hypertrophy.

  1995cited by this paper
• Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.

  1995cited by this paper
• Antihypertensive effect of an endothelin receptor antagonist in DOCA‐salt spontaneously hypertensive rats

  1995cited by this paper
• Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats.

  1995cited by this paper
• Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat.

  1995cited by this paper
• Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.

  1995cited by this paper
• In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

  1995cited by this paper
• Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase.

  1994cited by this paper
• Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

  1994cited by this paper
• Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt.

  1994cited by this paper
• Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries.

  1994cited by this paper
• Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat.

  1993cited by this paper
• Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

  1993cited by this paper
• Is endothelin involved in the pathogenesis of hypertension?

  1993cited by this paper
• Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.

  1993cited by this paper
• Cardiac weight in hypertension induced by nitric oxide synthase blockade.

  1993cited by this paper
• Potential role of endothelin in hypertension. Controversy on endothelin in hypertension.

  1993cited by this paper
• Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition.

  1993cited by this paper
• Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.

  1993cited by this paper
• Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

  1993cited by this paper
• Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.

  1992cited by this paper
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.

  1992cited by this paper
• Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.

  1992cited by this paper
• Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats.

  1992cited by this paper
• Induction of Endothelin‐1 Gene by Angiotensin and Vasopressin in Endothelial Cells

  1992cited by this paper
• cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA.

  1991cited by this paper
• Plasma endothelin in human essential hypertension.

  1991cited by this paper
• Plasma endothelin during upright tilt: relevance for orthostatic hypotension?

  1991cited by this paper
• Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats

  1990cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Role of endothelium-derived nitric oxide in the regulation of blood pressure.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes.

  1983cited by this paper

• Beneficial effects of swimming and pomegranate juice in rats with hypertension: A possible role of serum adropin.

  2024cites this paper
• Vasorelaxant-Mediated Antihypertensive Effect of the Leaf Aqueous Extract from Stephania abyssinica (Dillon & A. Rich) Walp (Menispermaceae) in Rat

  2021cites this paper
• Exercise training with concomitant nitric oxide synthase inhibition improved anxiogenic behavior, spatial cognition, and BDNF/P70S6 kinase activation in 20-month-old rats.

  2018cites this paper
• Nitric oxide synthase inhibition impairs muscle regrowth following immobilization.

  2017cites this paper
• The Effect of Laser Acupuncture of Five-Transport-Points of the Heart Meridian in L-NAME-Induced Hypertensive Rats

  2017cites this paper
• End o' the line revisited: moving on from nitric oxide to CGRP.

  2014cites this paper
• in the vasculature: new perspectives The interaction between endothelin-1 and nitric oxide

  2011cites this paper
• The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives.

  2011cites this paper
• Regular Exercise Produced Cardioprotective Effects on Rat's Heart with Hypertension Induced by L-NAME Administration

  2009cites this paper
• CHAPTER 15 – Kinins and Endothelin

  2008cites this paper
• The endocrine system in chronic nitric oxide deficiency.

  2007cites this paper
• Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.

  2006cites this paper
• Reactive Species-Mediated Regulation of Cell Signaling and the Cell Cycle: The Role of MAPK

  2005cites this paper
• The potential of endothelin antagonism as a therapeutic approach

  2004cites this paper
• Role of endothelins in animal models of hypertension: focus on cardiovascular protection.

  2003cites this paper
• Participation of renal and circulating endothelin in salt-sensitive essential hypertension

  2002cites this paper
• Combination of Low-Dose Valsartan and Enalapril Improves Endothelial Dysfunction and Coronary Reserve in Nω-Nitro-l-Arginine Methyl Ester–Treated Spontaneously Hypertensive Rats

  2002cites this paper
• Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload.

  2002cites this paper
• Role of endothelin-1 in hypertension and vascular disease.

  2001cites this paper
• An update on the status of endothelin receptor antagonists for hypertension

  2001cites this paper
• Therapeutic Role of Bosentan in Hypertension: Lessons from the Model of Perinephritic Hypertension

  2001cites this paper
• Crosstalk Between Endothelin and Nitric Oxide in the Control of Vascular Tone

  2001cites this paper
• Temporal regulation of endothelial ET-1 and eNOS expression in intact human conduit vessels exposed to different intraluminal pressure levels at physiological shear stress.

  2000cites this paper
• 7 Oxide and Hypertension

  2000cites this paper
• Endothelin and ET(A) receptors in long-term arterial pressure homeostasis in conscious nonhuman primates.

  2000cites this paper
• Altered flow-induced arterial remodeling in vimentin-deficient mice.

  2000cites this paper
• Increased activity of endogenous endothelin in patients with hypercholesterolemia.

  2000cites this paper
• ENDOTHELIN AND BLOOD PRESSURE REGULATION IN THE FEMALE RAT: STUDIES IN NORMAL PREGNANCY AND WITH NITRIC OXIDE SYNTHASE INHIBITION-INDUCED HYPERTENSION

  2000cites this paper
• Nitric Oxide and Hypertension

  2000cites this paper
• Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats

  2000cites this paper
• Effect of endothelin blockade on pressure natriuresis in nitric oxide-deficient hypertensive rats.

  1999cites this paper
• Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.

  1999cites this paper
• Stimulation of the renin-angiotensin system by endothelin subtype A receptor blockade in conscious dogs.

  1999cites this paper
• Nephroangiosclerosis During Nitric Oxide Synthase Inhibition in Vascular Endothelin-1 Gene Expression and Synthesis and Effect on Renal Type

  1999cites this paper
• Role of endothelin-1 in hypertension

  1999cites this paper
• CHRONIC STUDIES ON THE INTERACTION BETWEEN NITRIC OXIDE AND ENDOTHELIN IN CARDIOVASCULAR AND RENAL FUNCTION

  1999cites this paper
• RELATIONSHIPS BETWEEN THE ENDOTHELIN AND NITRIC OXIDE PATHWAYS

  1999cites this paper
• Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.

  1999cites this paper
• Endothelin and its antagonists in hypertension: Can we foresee the future?

  1999cites this paper
• Endothelin receptor antagonists: novel agents for the treatment of hypertension?

  1999cites this paper
• State-of-the-Art lecture. Role of endothelin-1 in hypertension.

  1999cites this paper
• Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo.

  1999cites this paper
• Nitric oxide and the proliferation of vascular smooth muscle cells.

  1999cites this paper
• Endothelin-1 and Endothelin Receptor Antagonists in Cardiovascular Remodeling

  1999cites this paper
• Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock.

  1999cites this paper
• Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450‐derived arachidonate metabolites

  1998cites this paper
• Chronic nitric oxide inhibition model six years on.

  1998cites this paper
• Effect of chronic treatment with two different ETA selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats

  1998cites this paper
• Endothelin: role in hypertension.

  1998cites this paper
• The role of endothelin in hypertension

  1998cites this paper
• Endothelin in hypertension: a role for receptor antagonists?

  1998cites this paper
• Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats.

  1998cites this paper
• Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.

  1998cites this paper
• Mechanisms of Hypertension in the Chronic NOS Inhibition Model

  1998cites this paper
• Different Contributions of the Endothelin ETA Receptor to Hypertension Induced by Acute or Chronic Inhibition of Nitric Oxide Synthesis

  1998cites this paper
• Endothelin and endothelin antagonists in hypertension

  1998cites this paper
• Human Septic Shock Endothelin-1 and Blood Pressure After Inhibition of Nitric Oxide Synthesis in

  1998cites this paper
• Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.

  1998cites this paper
• Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.

  1998cites this paper
• Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent.

  1997cites this paper
• Apoptosis in aorta of deoxycorticosterone acetate‐salt hypertensive rats: effect of endothelin receptor antagonism

  1997cites this paper
• Effect of chronic ETA‐selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

  1997cites this paper
• Endothelial Function in Hypertension

  1997cites this paper
• Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.

  1997cites this paper
• Clinical significance of endothelin in cardiovascular disease

  1997cites this paper
• Endothelin in Hypertension: A Role in Vascular Hypertrophy?

  1997cites this paper
• E(cid:128)ect of chronic ET A -selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

  1997cites this paper